The FDA approved use of the Atalante X robotic exoskeleton, which allows people with mobility issues to stand upright, for MS rehabilitation.
Hosted on MSN
PoNS therapy shows promise for MS gait deficits
NEWTOWN, Pa. - Helius Medical Technologies, Inc. (NASDAQ:HSDT), a neurotech company with a market capitalization of $3.84 million, announced significant findings from the PoNS Therapeutic Experience ...
Please provide your email address to receive an email when new articles are posted on . Adults with MS took home videos of themselves walking and uploaded them to a digital platform. Video taken in ...
MedRhythms to receive a $3 million upfront payment as part of the agreement and is eligible to receive potential development and commercial milestone payments CAMBRIDGE, Mass. and PORTLAND, Maine, May ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results